Back
Atea Pharmaceuticals Stock Predictions
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
69
AVIR
Atea Pharmaceuticals
Last Price:
$3.50
Seasonality Move:
0.64%
7 Day Trial
ALL ACCESS PASS
$
7
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaAtea Pharmaceuticals Stock Forecast
-
Is Atea Pharmaceuticals Stock Undervalued?The current Atea Pharmaceuticals [AVIR] share price is $3.53. The Score for AVIR is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
AVIR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Atea Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Atea Pharmaceuticals Stock Rating
Data Unavailable
Atea Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ateapharma.com
52-Week Data
52-Week High:
4.15
52-Week Low:
2.46
Prediction Charts
Market Cap:
302.1M
Price in USD:
3.53
Volume:
449.8K
Beta:
0.18
Technical Analysis
SMA50:
3.00
SMA100:
3.01
SMA200:
3.19
52-Wk Change:
4.75%
Stock Predictions
-
Is Atea Pharmaceuticals stock public?Yes, Atea Pharmaceuticals is a publicly traded company.
-
What is the Atea Pharmaceuticals stock quote today?The Atea Pharmaceuticals stock price is 3.53 USD today.
-
How to buy Atea Pharmaceuticals stock online?You can buy Atea Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-6 | 3.22 | 3.18 | 3.24 | 3.09 |
| Jun-9 | 3.21 | 3.21 | 3.23 | 3.17 |
| Jun-10 | 3.22 | 3.22 | 3.35 | 3.17 |
| Jun-11 | 3.23 | 3.18 | 3.31 | 3.17 |
| Jun-12 | 3.16 | 3.21 | 3.28 | 3.16 |
| Jun-13 | 3.17 | 3.16 | 3.26 | 3.15 |
| Jun-16 | 3.19 | 3.19 | 3.28 | 3.16 |
| Jun-17 | 3.17 | 3.21 | 3.32 | 3.17 |
| Jun-18 | 3.20 | 3.21 | 3.32 | 3.18 |
| Jun-20 | 3.23 | 3.25 | 3.30 | 3.21 |
| Jun-23 | 3.25 | 3.32 | 3.37 | 3.23 |
| Jun-24 | 3.34 | 3.38 | 3.45 | 3.33 |
| Jun-25 | 3.37 | 3.47 | 3.51 | 3.35 |
| Jun-26 | 3.50 | 3.53 | 3.62 | 3.49 |
Atea Pharmaceuticals Earnings
Data Unavailable
Atea Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, an increase next quarter of $0.32 per share, a decrease this year of $0.21 per share, and an increase next year of $0.38 per share.
* Atea Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.